By 2020, it is estimated that there will be 21 billion connected devices in the world. That will be five times as many as just four years ago. This fact affects healthcare as much as any industry. Internet of Things (IoT) in Healthcare tracks the trends around IoT in healthcare and makes specific market estimates […]

With a demand in healthcare to lower unneeded emergency room visits and provide more options for patients, more and more customers will seek urgent care in the coming years.  This report will provide marketers and business planners with the important data they need on this emerging channel of business.  Kalorama has covered the urgent care […]

Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, […]

Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. The 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market. 2000-Page Report Based on Vendor Reporting, Interviews, […]

Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of […]

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several […]

  Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price.  This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their […]

In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and […]

Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in […]

Saving sample volume, cutting down provider time, reducing costs, improving outcomes, these are goals of the healthcare system, and they are well suited to a test that can identify more than a single pathogen. It has been thought that numerous pathogens tested directly from clinical specimens could change up diagnostics, and many vendors have responded […]